FDA panel backs approval of GSK asthma drug in adults – Reuters

FDA panel backs approval of GSK asthma drug in adults
Reuters
An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and older. The panel voted 10 to 4 against approving it in children aged …
UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in …StreetInsider.com
FDA committee recommends approval of Nucala for adults with severe asthmaHealio

all 8 news articles »